The role of tumour microenvironment in neoplasm initiation and malignant evolution has been increasingly recognized. However, the bone marrow mesenchymal stromal cell (BMMSC) contribution to disease progression remains poorly explored.
| BACKGROUND
Serine protease inhibitor kunitz-type 2 (SPINT2) codes the HAI-2 transmembrane protein. The HAI-2 protein is responsible for the inhibition of the enzyme hepatocyte growth factor activator (HGFA). When active, HGFA is responsible for proteolytic cleavages of the inactive form of the hepatocyte growth factor (pro-HGF) into HGF active form. 1 HGF is a multifunctional polypeptide that regulates diverse biological processes such as cell growth, apoptosis, cytokines secretion, adhesion, survival of hematopoietic cells, anti-inflammation, and immune-regulation. 2, 3 HGF is secreted by mesenchymal stromal cells (MSC) and the action of this peptide is mediated by c-met tyrosine kinase pro-oncogene transmembrane receptor. 4 Interestingly, HGF cytokine serum levels are significantly increased in myelodysplastic syndromes (MDS) and de novo acute myeloid leukaemia (de novo AML) patients, both heterogeneous diseases, which are prevalent in the elderly, and are a prognostic marker that could predict survival. 5, 6 Low levels of SPINT2/HAI-2, probably due to hypermethylation, have been highlighted in various solid cancer types and have been associated with disease progression. [7] [8] [9] [10] [11] [12] [13] Pereira and colleagues hypothesized that SPINT2/HAI-2 is involved in prostate cancer tumourigenesis probably by regulation of SPINT2/HAI-2. 7 We previously reported that the expression of SPINT2 mRNA is significantly lower in bone marrow mesenchymal stromal cell (BMMSC) from MDS patients compared to healthy donors (HD), which could be related with increased HGF and CXCL-12 secretion. 14 Despite being related to the pathogenesis of several neoplasms, the role of SPINT2/HAI-2 has not yet been fully elucidated in haematological malignances, such as MDS and de novo AML. Thus, in this study, we investigate whether this loss of expression was due to SPINT2/HAI-2 methylation in order to better understand the role of SPINT2/HAI-2 down-regulation in MDS and de novo AML physiopathology and its contribution to leukaemic bone marrow microenvironment.
| MATERIALS AND METHODS

| Cell
| Mesenchymal stromal cell
The BM mononuclear cells were isolated using Ficoll-Hypaque Plus density-gradient centrifugation (GE Healthcare). The mononuclear cells were plated onto Dulbecco's modified Eagle's medium (DMEM) (Sigma) supplemented foetal bovine serum (FBS), glutamine, 100 μg/ mL penicillin, 100 μg/mL streptomycin, and amphotericin B in a humidified 5% carbon dioxide and 95% air incubator at 37°C. The supernatant with nonadherent cells was removed weekly and replaced with fresh supplemented medium. When the monolayer was established (approximately 90% confluence), cells were trypsinized and plated under the same conditions. After replating them three times, a homogeneous cell population was obtained and MSC were evaluated by flow cytometry for the absence of CD31, CD34, CD45, CD68, and HLA-DR antigens and the presence of CD73, CD90, and CD105. 
| HS-5 stromal cells
| Azacytidine treatment
Mesenchymal stromal feeder layers from 1 HD-BMMSC, 1 MDS- 
| Quantitative polymerase chain reaction (qPCR)
Total RNA was extracted from cells using the RNeasy Micro Kit (Qiagen) and cDNA was generated using RevertAid H Minus First
Strand cDNA Synthesis Kit (Thermo Fisher Scientific). qRT-PCR was performed with SYBR Green Master Mix PCR (Thermo Fisher Scientific) using the ABI 7500 Sequence Detection System (Applied-Biosystem). The relative quantification gene expression values were calculated using the equation 2 −ΔΔCT15 with the housekeeping genes hypoxanthine guanine phosphoribosyltransferase 1 (HPRT1), beta actin (ACTB), and glyceraldehyde-3-phosphate desidrogenase (GAPDH).
The control was performed for each primer pair. Amplification specificity was verified using a dissociation curve at the end of each run.
Three replicas were run on the same plate for each sample. 
| Western blot
| HGF secretion
| Statistical analysis
Statistical analysis was performed using GraphPad Prism5 software. 3 | RESULTS
| Increased SPINT2 gene and HAI-2 protein expression after MDS-BMMSC and AML-BMMSC treatment with AZA
As we previously observed a significantly decreased expression of SPINT2 mRNA in MDS-BMMSC compared to HD-BMMSC, 14 we evaluated SPINT2 mRNA and HAI-2 expression in 1 HD-BMMSC, Moreover, transduced stromal cells were infused into a bioscaffold and were cultured for 7 days. We observed an improvement in cell growth into the bioscaffold containing cells with SPINT2/HAI-2 depletion ( Figure 3A,B) . Moreover, our immunohistochemistry analysis showed that the SPINT2/HAI-2 silenced cell-seeded scaffold expressed more HGF than the control silenced cells (Figure 3C,D) .
As HGF is capable of maintaining the stromal microenvironment niche, promoting hematopoiesis by inducing constitutive production of CXCL12, we also analysed CXCL12 expression. Interestingly, the SPINT2/HAI-2 silenced cell-seeded scaffold expressed more CXCL12
than the control silenced cells (Figure 3E,F) . Since the matrix is ROVERSI ET AL. 
| DISCUSSION
In recent years, the role of tumour microenvironment niche in neoplasm initiation and malignant evolution/progression has been increasingly recognized. Leukemic stem cells are capable of modifying the interaction between hematopoietic stem cells and the bone marrow microenvironment to induce leukemogenesis. 16 However, the contribution of BMMSC to disease progression remains poorly explored. We had previously performed a microarray analysis of MDS patient-derived BMMSC (MDS-BMMSC) 17 and, after primary . Experiments were performed in triplicate. Western blotting was done using protein extracted from total cell. The membrane was blotted with antibodies against SPINT2/HAI-2 (34 KDa), DMNT3a (130 KDa), or GAPDH (37 kDa), as a control for equal sample loading, and developed with the ECL Western Blotting Analysis System. P values are indicated and correspond to the difference between BMMSC treated with vehicle (DMSO) and BMMSC treated with Aza for each sample growth, and cell survival of hematopoietic cells through MET pathways. 18 In MDS and de novo AML patients, the levels of HGF cytokine in the serum are significantly increased and represent a predictor of survival. 5, 6 Kentsis and colleagues showed that up-regulation of HGF expression was responsible for the maintenance of leukemogenic signalling. 19 In diverse tumours, the down-regulation of SPINT2 expression has been associated with gene promoter hypermethylation. [7] [8] [9] [10] [11] [12] [13] AZA is a DNA methyltransferase inhibitor 20 that has been successfully used in epigenetic neoplastic therapy to reactivate epigenetically silenced tumour suppressor genes. 21 Furthermore, AZA is the firstline treatment for patients with high-risk myelodysplastic syndrome and has been successful in prolonging survival and delayed AML evolution. 22 These findings prompted us to examine whether methylation-mediated epigenetic silencing SPINT2/HAI-2 was involved in Myelodysplastic Syndrome and de novo AML pathophysiology.
Therefore, we obtained primary BMMSCs from healthy donor (HD), MDS, and de novo AML patients, isolated from bone marrow mononuclear cells. HD-BMMSC, MDS-BMMSC, and de novo AML-BMMSC were then treated with AZA. SPINT2 gene and HAI-2 protein expressions levels were evaluated by qPCR and Western blot.
We observed a significant increase in SPINT2/HAI-2 levels after AZA Mesenchymal stromal cells production of HGF has protective effects on hematopoietic cells due to anti-inflammatory, anti-fibrotic, anti-apoptotic, and cell-to-cell adhesion mechanisms. 2, 3 Crosstalk between MSC and hematopoietic stem cells, in the bone marrow microenvironment, are essential to support stem cell behaviour and contribute to abnormal hematopoietic cell growth, survival, and maturation. 24, 25 Moreover, the cell-to-cell contact between BMMSC and myelodysplastic and leukemic stem cells is important for cell selfrenewal, proliferation, and survival as well as for leukemogenesis. 26, 27 In this concern, we evaluated the contribution of SPINT2/HAI-2 
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